 |
|
Physician Knowledge, Attitudes, and Behavior Related to Reporting Adverse Drug Events
Audrey Smith Rogers, PhD;
Ebenezer Israel, MD;
Craig R. Smith, MD;
David Levine, MD, ScD;
A. Marshall McBean, MD;
Carmine Valente, PhD;
Gerald Faich, MD
Arch Intern Med. 1988;148(7):1596-1600.
Abstract
• Voluntary physician reporting of adverse drug events (ADEs) in their patients remains the single most important source of information on serious and rare ADEs. Yet, substantial underreporting exists and the factors producing it are unclear. We surveyed 3000 randomly chosen physicians by mailed questionnaire to determine their knowledge about the reporting system, attitudes toward reporting, and their past behavior in reporting the ADEs they had detected. Responses numbered 1121. Only 57% were aware of the Food and Drug Administration's reporting system. While 418 physicians had detected an ADE in their practices during the previous year, only 21 physicians reported these events directly to the Food and Drug Administration. The physicians appear to appreciate the safety issues involved in prescription drug use and view reporting as a professional obligation; however, the current reporting system is considered inconvenient.
(Arch Intern Med 1988;148:1596-1600)
Author Affiliations
From The Johns Hopkins University School of Medicine, Baltimore (Drs Rogers, Smith, and Levine); State of Maryland Department of Health and Mental Hygiene, Baltimore (Dr Israel); The Johns Hopkins University School of Hygiene and Public Health, Baltimore (Dr McBean); The Center for Health Education, Baltimore (Dr Valente); and the Department of Epidemiology and Biostatistics, Food and Drug Administration, Rockville, Md (Dr Faich).
Footnotes
Accepted for publication Nov 18, 1987.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Bleeding Complications With Warfarin Use: A Prevalent Adverse Effect Resulting in Regulatory Action
Wysowski et al.
Arch Intern Med 2007;167:1414-1419.
ABSTRACT
| FULL TEXT
A Review of Medical Error Reporting System Design Considerations and a Proposed Cross-Level Systems Research Framework
Holden and Karsh
Human Factors: The Journal of the Human Factors and Ergonomics Society 2007;49:257-276.
ABSTRACT
Computerized surveillance of adverse drug events in hospital patients
Classen et al.
Qual Saf Health Care 2005;14:221-226.
ABSTRACT
| FULL TEXT
No-Fault Compensation for Medical Injuries: The Prospect for Error Prevention
Studdert and Brennan
JAMA 2001;286:217-223.
ABSTRACT
| FULL TEXT
Dermatologic Adverse Drug Reactions in a Family Medicine Setting
Ives et al.
Arch Fam Med 1992;1:241-245.
ABSTRACT
Computerized Surveillance of Adverse Drug Events in Hospital Patients
Classen et al.
JAMA 1991;266:2847-2851.
ABSTRACT
National Adverse Drug Reaction Reporting: 1984-1989
Faich
Arch Intern Med 1991;151:1645-1647.
ABSTRACT
Physician Reporting of Adverse Drug Reactions: Results of the Rhode Island Adverse Drug Reaction Reporting Project
Scott et al.
JAMA 1990;263:1785-1788.
ABSTRACT
Medication and the Elderly: Issues of Prescription and Use
German and Burton
J Aging Health 1989;1:4-34.
ABSTRACT
Implementing a Hospital-Based Adverse Drug Reaction Reporting Program
Miwa
Journal of Pharmacy Practice 1989;2:214-220.
ABSTRACT
Adverse Drug Event Reporting: Improving the Low US Reporting Rates
Edlavitch
Arch Intern Med 1988;148:1499-1503.
ABSTRACT
|
